Literature DB >> 3119676

Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.

J M Theaker1, A E Raine, A J Rainey, A Heryet, A Clark, D O Oliver.   

Abstract

A patient receiving long-term haemodialysis developed systemic amyloidosis, which was shown immunohistochemically to be of beta 2-microglobulin type, a previously unrecognised form of systemic amyloidosis. Histologically, the amyloid deposits were closely associated with foci of acute and granulomatous inflammation and vasculitis, although it was not clear if the amyloid deposits directly caused the inflammatory process, or if amyloid was deposited preferentially in areas of inflammation of uncertain aetiology.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3119676      PMCID： PMC1141204          DOI： 10.1136/jcp.40.10.1247

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  15 in total

1.  Dialysis arthropathy: amyloid or iron?

Authors:  N R Cary; D Sethi; E A Brown; C C Erhardt; D F Woodrow; P E Gower
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

2.  Amyloidosis of a possible new type in patients receiving long-term hemodialysis.

Authors:  T Morita; M Suzuki; A Kamimura; Y Hirasawa
Journal:  Arch Pathol Lab Med       Date:  1985-11       Impact factor: 5.534

3.  Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.

Authors:  F Gejyo; N Homma; Y Suzuki; M Arakawa
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

4.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin.

Authors:  F Gejyo; T Yamada; S Odani; Y Nakagawa; M Arakawa; T Kunitomo; H Kataoka; M Suzuki; Y Hirasawa; T Shirahama
Journal:  Biochem Biophys Res Commun       Date:  1985-06-28       Impact factor: 3.575

5.  Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment.

Authors:  H G Kachel; P Altmeyer; C A Baldamus; K M Koch
Journal:  Contrib Nephrol       Date:  1983       Impact factor: 1.580

6.  Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis.

Authors:  M S Dunnill; P R Millard; D Oliver
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

7.  Hepatic copper distribution in primary biliary cirrhosis shown by the scanning proton microprobe.

Authors:  D J Vaux; F Watt; G W Grime; J Takacs
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

8.  Beta-2 microglobulin is an amyloidogenic protein in man.

Authors:  P D Gorevic; T T Casey; W J Stone; C R DiRaimondo; F C Prelli; B Frangione
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Carpal tunnel syndrome: a major complication in long-term hemodialysis patients.

Authors:  A Schwarz; F Keller; S Seyfert; W Pöll; M Molzahn; A Distler
Journal:  Clin Nephrol       Date:  1984-09       Impact factor: 0.975

10.  Accumulation of silicone elastomer in regular dialysis.

Authors:  T Laohapand; E M Osman; A R Morley; M K Ward; D N Kerr
Journal:  Proc Eur Dial Transplant Assoc       Date:  1983
View more
  9 in total

1.  Systemic amyloidosis of beta 2 microglobulin type.

Authors:  K Mazanec; J McClure; C J Bartley; M J Newbould; P Ackrill
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

2.  Beta 2 microglobulin haemodialysis related amyloidosis: distinctive gross features of gastrointestinal involvement.

Authors:  M Shimizu; T Manabe; T Matsumoto; Y Monobe; M Hirokawa; T Moriya; M Iida
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  Gastrointestinal complications of dialysis related amyloidosis.

Authors:  E R Maher; S H Dutoit; R A Baillod; P Sweny; J F Moorhead
Journal:  BMJ       Date:  1988-07-23

4.  Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis.

Authors:  J Fernández-Alonso; C Rios-Camacho; A Valenzuela-Castaño; J L Rocha-Castilla
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

5.  Generalized amyloidosis from beta 2-microglobulin, with caecal perforation after long-term haemodialysis.

Authors:  H Zhou; U Pfeifer; R Linke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.

Authors:  T Miyata; O Oda; R Inagi; Y Iida; N Araki; N Yamada; S Horiuchi; N Taniguchi; K Maeda; T Kinoshita
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.

Authors:  T Miyata; R Inagi; Y Iida; M Sato; N Yamada; O Oda; K Maeda; H Seo
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  Cystic beta2-microglobulin amyloidoma in a patient on long-term hemodialysis.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Junko Takahashi; Ken Takahashi; Akira Shiokawa; Takashi Kitanosono; Eriko Kinugasa; Susumu Taguchi
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.617

9.  Association of a high normalized protein catabolic rate and low serum albumin level with carpal tunnel syndrome in hemodialysis patients.

Authors:  Wen-Hung Huang; Ching-Wei Hsu; Cheng-Hao Weng; Tzung-Hai Yen; Jui-Hsiang Lin; Meng Lee
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.